Literature DB >> 1852382

Nd:YAG cyclophotocoagulation: outcome of treatment for uncontrolled glaucoma.

M M Wright1, A L Grajewski, W J Feuer.   

Abstract

We reviewed the records of 35 patients (35 eyes) treated with Nd:YAG cyclophotocoagulation for uncontrolled glaucoma and followed for 6 to 36 months or until treatment was declared a failure (loss of light perception, or intraocular pressure (IOP) greater than 21 mm Hg). The mean pretreatment intraocular pressure was 37.9 mm Hg (range, 20 to 61 mm Hg). The total energy in the initial treatment session ranged from 50.4 to 372.4 J (191.7 +/- 66.3 J). After the treatment, the mean IOP was 21.2 mm Hg (range, 0 to 53 mm Hg). The Kaplan Meier survival analysis demonstrated that failures occurred throughout the follow-up period and that the majority of patients required further intervention or lost all vision if followed long enough. Visual outcome was not correlated with energy used. Eleven eyes (31%) lost two or more lines of acuity or lost all light perception. These findings suggest that Nd:YAG cyclophotocoagulation may control IOP but cannot always save vision.

Entities:  

Mesh:

Year:  1991        PMID: 1852382

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  10 in total

1.  Initial experience with a new method of laser transscleral cyclophotocoagulation for ciliary ablation in severe glaucoma.

Authors:  D E Gaasterland; I P Pollack
Journal:  Trans Am Ophthalmol Soc       Date:  1992

2.  Controlled cyclophotocoagulation with the 940 nm laser for primary open angle glaucoma in African eyes.

Authors:  Paul-Rolf Preussner; Faustin Ngounou; Gabriel Kouogan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-02       Impact factor: 3.117

Review 3.  [Controlled cyclophotocoagulation (COCO) : What needs to be considered?]

Authors:  P-R Preußner
Journal:  Ophthalmologe       Date:  2018-04       Impact factor: 1.059

4.  Steps to optimize transscleral photocoagulation.

Authors:  P R Preussner; O Schwenn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-05       Impact factor: 3.117

5.  Transvitreal endocyclophotocoagulation.

Authors:  J A Haller
Journal:  Trans Am Ophthalmol Soc       Date:  1996

6.  Real-time control for transscleral cyclophotocoagulation.

Authors:  P R Preussner; N Boos; K Fassbender; O Schwenn; N Pfeiffer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-12       Impact factor: 3.117

7.  Contact transscleral neodymium:yttrium-aluminum-garnet laser cyclophotocoagulation Long-term outcome.

Authors:  Patty Lin; Gadi Wollstein; Ioannis P Glavas; Joel S Schuman
Journal:  Ophthalmology       Date:  2004-11       Impact factor: 12.079

Review 8.  Endoscopic cyclophotocoagulation.

Authors:  S Lin
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

9.  Vascular effects on ciliary tissue from endoscopic versus trans-scleral cyclophotocoagulation.

Authors:  S C Lin; M J Chen; M S Lin; E Howes; R L Stamper
Journal:  Br J Ophthalmol       Date:  2006-04       Impact factor: 4.638

10.  Clinical options for the reduction of elevated intraocular pressure.

Authors:  Laura Crawley; Sohaib M Zamir; Maria F Cordeiro; Li Guo
Journal:  Ophthalmol Eye Dis       Date:  2012-04-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.